Epidemiologic features of four successive annual outbreaks of bubonic plague in Mahajanga, Madagascar

Emerging Infectious Diseases
P BoisierSuzanne Chanteau

Abstract

From 1995 to 1998, outbreaks of bubonic plague occurred annually in the coastal city of Mahajanga, Madagascar. A total of 1,702 clinically suspected cases of bubonic plague were reported, including 515 laboratory confirmed by Yersinia pestis isolation (297), enzyme-linked immunosorbent assay, or both. Incidence was higher in males and young persons. Most buboes were inguinal, but children had a higher frequency of cervical or axillary buboes. Among laboratory-confirmed hospitalized patients, the case-fatality rate was 7.9%, although all Y. pestis isolates were sensitive to streptomycin, the recommended antibiotic. In this tropical city, plague outbreaks occur during the dry and cool season. Most cases are concentrated in the same crowded and unsanitary districts, a result of close contact among humans, rats, and shrews. Plague remains an important public health problem in Madagascar, and the potential is substantial for spread to other coastal cities and abroad.

References

Nov 4, 1995·Lancet·M RasolomaharoS Chanteau
May 1, 1997·Tropical Medicine & International Health : TM & IH·P BoisierS Chanteau
Sep 4, 1997·The New England Journal of Medicine·M GalimandP Courvalin
Dec 23, 1998·Transactions of the Royal Society of Tropical Medicine and Hygiene·S ChanteauM Rasolomaharo
Mar 16, 2000·Microbes and Infection·S ChanteauJ Roux
Aug 26, 2000·International Journal of Medical Microbiology : IJMM·S ChanteauJ Burans

❮ Previous
Next ❯

Citations

Jan 28, 2003·Lancet·David T Dennis, May C Chu
Oct 2, 2002·Current Opinion in Microbiology·Peter H Gilligan
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Daniel J SalkeldJames Holland Jones
Dec 30, 2008·Molecular & Cellular Proteomics : MCP·Sarah L KeaseyRobert G Ulrich
Mar 19, 2008·Infection and Immunity·Lauriane E QueneeOlaf Schneewind
Sep 17, 2008·Infection and Immunity·Claire A CorneliusOlaf Schneewind
Jul 26, 2005·Infection and Immunity·Katie A OverheimOlaf Schneewind
Sep 21, 2011·PLoS Neglected Tropical Diseases·Amy J VoglerPaul Keim
Nov 19, 2013·PLoS Neglected Tropical Diseases·Voahangy AndrianaivoarimananaRonan Jambou
May 6, 2006·Emerging Infectious Diseases·Min LiRuifu Yang
Oct 5, 2010·The American Journal of Tropical Medicine and Hygiene·Sean P MaherA Townsend Peterson
May 17, 2011·Journal of Archaeological Science·Sharon N Dewitte
Apr 10, 2007·Lancet·Michael B Prentice, Lila Rahalison
Jan 14, 2009·American Journal of Physical Anthropology·Sharon N DeWitte
Aug 15, 2006·Tropical Medicine & International Health : TM & IH·René MiglianiJean Roux
Sep 15, 2012·American Journal of Physical Anthropology·Sharon N Dewitte
Mar 17, 2011·The American Journal of Pathology·Lauriane E QueneeOlaf Schneewind
Aug 12, 2016·MMWR. Morbidity and Mortality Weekly Report·Nyambe SinyangeLottie Hachaambwa
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Joseph A Lewnard, Jeffrey P Townsend
Jul 28, 2016·Epidemiology and Health·Abdolrazagh Hashemi ShahrakiEhsan Mostafavi
Nov 21, 2017·PLoS Neglected Tropical Diseases·Soanandrasana RahelinirinaJean-Marc Duplantier
Jan 12, 2019·Journal of Medical Microbiology·Ali A RabaanShafiul Haque
Mar 6, 2016·Applied and Environmental Microbiology·Ian M GutDavid K R Karaolis
Aug 5, 2018·Proceedings of the National Academy of Sciences of the United States of America·Katharine R DeanBoris V Schmid
Jan 23, 2019·Emerging Infectious Diseases·Voahangy AndrianaivoarimananaMinoarisoa Rajerison
Sep 6, 2017·PLoS Neglected Tropical Diseases·Amy J VoglerMinoarisoa Rajerison
Apr 1, 2006·The Journal of Experimental Biology·Phillip Bergmann, Duncan J Irschick
Jun 12, 2021·BMC Public Health·Sitraka RakotosamimananaMinoarisoa Rajerison
Jul 4, 2003·The Journal of the American Dental Association·Susan Z HanE Dianne Rekow
Jan 29, 2011·The Lancet Infectious Diseases·Emilie AlirolLouis Loutan

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA
enzyme-linked immunosorbent-assay
genotyping
electrophoresis
ELISAs

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.